{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:41:25Z","timestamp":1790890885021,"version":"4.1.0"},"reference-count":36,"publisher":"AVES YAYINCILIK A.\u015e.","issue":"3","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Rheumatology"],"abstract":"<jats:p>Objectives: The study aimed to investigate and compare clinical features, disease activity, and the overall disease burden among psoriatic arthritis (PsA) patients across seven distinct geographic regions in T\u00fcrkiye.\r\n Patients and methods: A multicenter cross-sectional study involving 1,134 PsA patients from 25 referral centers across seven regions was conducted. Demographic and clinical characteristics, comorbidities, joint involvement, extra-articular manifestations, and disease activity measures were evaluated across regions.\r\n Results: A total of 1134 PsA patients from seven different geographic regions in T\u00fcrkiye participated in this study. The highest number of participants was from the Marmara region (n=409), with subsequent representation from Central Anatolia (n=370), Aegean (n=139), Mediterranean (n=60), Black Sea (n=60), Eastern Anatolia (n=60), and Southeastern Anatolia (n=36) regions. There were significant variations in demographic profile, including age, body mass index, age of disease onset, educational status, comorbidities, and family history of both psoriasis and PsA. Clinical features, such as enthesitis, dactylitis, uveitis, and joint involvement, demonstrated significant variation across regions. Additionally, disease activity measures, including pain, patient and physician global assessments, acute phase reactants, disease activity indices, quality of life, and functional status, displayed considerable regional differences.\r\n Conclusion: This nationwide study revealed substantial regional diversity in demographic data, clinical characteristics, disease activity, and quality of life among PsA patients in T\u00fcrkiye. These findings stress the need to customize treatment approaches to address regional needs and to conduct further research to uncover reasons for disparities. It is crucial to enhance region-specific approaches to improve patient care and outcomes for PsA.<\/jats:p>","DOI":"10.46497\/archrheumatol.2024.10591","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:33:43Z","timestamp":1724830423000},"page":"339-349","source":"Crossref","is-referenced-by-count":3,"title":["Regional variations in psoriatic arthritis: Insights from a nationwide multicenter analysis in T\u00fcrkiye"],"prefix":"10.5152","volume":"39","author":[{"family":"Ya\u015far Keskin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Y\u0131ld\u0131ray Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Fikriye Figen Ayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hatice Bodur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mustafa \u00c7al\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Erhan \u00c7apk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"G\u00fcl Devrimsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kevser Orhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sami Hizmetli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ayhan Kamanl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Meltem Alkan Meliko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hilal Ecesoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"\u00d6znur Kutluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nesrin \u015een","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"\u00d6mer Faruk \u015eendur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sena Tolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Murat Toprak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Tiraje Tuncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kemal Nas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"\u0130lknur Albayrak Gezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Gamze K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"\u0130brahim Tekeo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Bet\u00fcl Sarg\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sevtap Acer Kasman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hakan Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nilay \u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Gizem Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nihan C\u00fczdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Erkan K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Dilek Keskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Cevriye M\u00fclko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hatice Re\u015forlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"\u0130smihan Sunar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ajda Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mehmet Tuncay Duru\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Okan K\u00fc\u00e7\u00fckakka\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ozan Volkan Yurdakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3111","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: Epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64 Suppl 2:ii14-7. doi: 10.1136\/ard.2004.032482.","DOI":"10.1136\/ard.2004.032482"},{"key":"ref-2","doi-asserted-by":"crossref","unstructured":"Gupta S, Syrimi Z, Hughes DM, Zhao SS. Comorbidities in psoriatic arthritis: A systematic review and meta-analysis. Rheumatol Int 2021;41:275- 84. doi: 10.1007\/s00296-020-04775-2.","DOI":"10.1007\/s00296-020-04775-2"},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Nas K, Karkucak M, Durmus B, Karatay S, Capk\u0131n E, Kaya A, et al. Comorbidities in patients with psoriatic arthritis: A comparison with rheumatoid arthritis and psoriasis. Int J Rheum Dis 2015;18:873-9. doi: 10.1111\/1756-185X.12580.","DOI":"10.1111\/1756-185X.12580"},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Mease PJ, Liu C, Siegel E, Richmond H, Wu M, Chen L, et al. Impact of clinical specialty setting and geographic regions on disease management in patients with psoriatic arthritis in the United States: A multicenter observational study. Am J Clin Dermatol 2019;20:873-80. doi: 10.1007\/s40257- 019-00470-6.","DOI":"10.1007\/s40257-019-00470-6"},{"key":"ref-5","unstructured":"McInnes IB. Psoriatic arthritis: Embracing pathogenetic and clinical heterogeneity? Clin Exp Rheumatol 2016;34(4 Suppl 98):9-11."},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Solmaz D, Eder L, Aydin SZ. Update on the epidemiology, risk factors, and disease outcomes of psoriatic arthritis. Best Pract Res Clin Rheumatol 2018;32:295-311. doi: 10.1016\/j.berh.2018.09.006.","DOI":"10.1016\/j.berh.2018.09.006"},{"key":"ref-7","doi-asserted-by":"crossref","unstructured":"Bakirci S, Ayan G, Gazel U, Tinazzi I, Solmaz D, Kasapoglu E, et al. Patient characteristics and minimal disease activity in psoriatic arthritis: A transcontinental comparison. Clin Rheumatol 2021;40:3169-74. doi: 10.1007\/s10067-021-05648-0.","DOI":"10.1007\/s10067-021-05648-0"},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Bittar M, Yong WC, Magrey M, Khan MA. Worldwide differences in clinical phenotype of axial spondyloarthritis. Curr Rheumatol Rep 2021;23:76. doi: 10.1007\/s11926-021-01043-5.","DOI":"10.1007\/s11926-021-01043-5"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global prevalence of spondyloarthritis: A systematic review and meta-regression analysis. Arthritis Care Res (Hoboken) 2016;68:1320-31. doi: 10.1002\/ acr.22831.","DOI":"10.1002\/acr.22831"},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Medina C, Molto A, Sieper J, Duru\u00f6z T, Kiltz U, Elzorkany B, et al. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: Results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open 2021;7:e001450. doi: 10.1136\/ rmdopen-2020-001450.","DOI":"10.1136\/rmdopen-2020-001450"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"K\u0131l\u0131\u00e7 G, K\u0131l\u0131\u00e7 E, Tekeo\u011flu \u0130, Sarg\u0131n B, Cengiz G, Balta NC, et al. Diagnostic delay in psoriatic arthritis: Insights from a nationwide multicenter study. Rheumatol Int 2024;44:1051-9. doi: 10.1007\/s00296-023-05479-z.","DOI":"10.1007\/s00296-023-05479-z"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"K\u0131l\u0131\u00e7 G, K\u0131l\u0131\u00e7 E, Tekeo\u011flu \u0130, Sarg\u0131n B, Cengiz G, Balta NC, et al. Beyond expectations: Disease duration and psychological burden in psoriatic arthritis. Rheumatol Int 2023;43:1695-704. doi: 10.1007\/s00296-023- 05379-2.","DOI":"10.1007\/s00296-023-05379-2"},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Keskin Y, Nas K, Kili\u00e7 E, Sargin B, Acer Kasman S, Alkan H, et al. Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs. Arch Rheumatol 2020;36:1-9. doi: 10.46497\/ArchRheumatol.2021.7874.","DOI":"10.46497\/ArchRheumatol.2021.7874"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 2006;54:2665- 73. doi: 10.1002\/art.21972.","DOI":"10.1002\/art.21972"},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Helliwell PS, FitzGerald O, Fransen J. Composite disease activity and responder indices for psoriatic arthritis: A report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response. J Rheumatol 2014;41:1212-7. doi: 10.3899\/jrheum.140172.","DOI":"10.3899\/jrheum.140172"},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS. Application of the DAREA\/ DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 2010;69:1441-7. doi: 10.1136\/ard.2009.122259.","DOI":"10.1136\/ard.2009.122259"},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: A proposed objective target for treatment. Ann Rheum Dis 2010;69:48-53. doi: 10.1136\/ard.2008.102053.","DOI":"10.1136\/ard.2008.102053"},{"key":"ref-18","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91."},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. doi: 10.1111\/j.1600-0447.1983. tb09716.x.","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"K\u00fc\u00e7\u00fckdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A. Issues in cross-cultural validity: Example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 2004;51:14-9. doi: 10.1002\/art.20091.","DOI":"10.1002\/art.20091"},{"key":"ref-21","unstructured":"Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994;21:1694-8."},{"key":"ref-22","doi-asserted-by":"crossref","unstructured":"Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996;106:183-6. doi: 10.1111\/1523- 1747.ep12329912.","DOI":"10.1111\/1523-1747.ep12329912"},{"key":"ref-23","doi-asserted-by":"crossref","unstructured":"Celiker R, Altan L, Rezvani A, Aktas I, Tastekin N, Dursun E, et al. Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST). J Phys Ther Sci 2017;29:340-4. doi: 10.1589\/jpts.29.340.","DOI":"10.1589\/jpts.29.340"},{"key":"ref-24","doi-asserted-by":"crossref","unstructured":"Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health Qual Life Outcomes 2003;1:79. doi: 10.1186\/1477-7525-1-79.","DOI":"10.1186\/1477-7525-1-79"},{"key":"ref-25","doi-asserted-by":"crossref","unstructured":"McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: A quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162-9. doi: 10.1136\/ ard.2003.006296.","DOI":"10.1136\/ard.2003.006296"},{"key":"ref-26","doi-asserted-by":"crossref","unstructured":"T\u00e4lli S, Etcheto A, Fautrel B, Balanescu A, Braun J, Ca\u00f1ete JD, et al. Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study. Joint Bone Spine 2016;83:335-40. doi: 10.1016\/j. jbspin.2015.06.018.","DOI":"10.1016\/j.jbspin.2015.06.018"},{"key":"ref-27","doi-asserted-by":"crossref","unstructured":"Shafrin J, Griffith J, Shim JJ, Huber C, Ganguli A, Aubry W. Geographic variation in diagnostic ability and quality of care metrics: A case study of ankylosing spondylitis and low back pain. Inquiry 2017;54:46958017707873. doi: 10.1177\/0046958017707873.","DOI":"10.1177\/0046958017707873"},{"key":"ref-28","doi-asserted-by":"crossref","unstructured":"Deodhar A, Kruzikas D, Zhou L, Biljan A, Saffore CD. Geographic variations in diagnosis and treatment of ankylosing spondylitis in the United States: A realworld study. Rheumatol Ther 2022;9:447-63. doi: 10.1007\/s40744-021-00406-9.","DOI":"10.1007\/s40744-021-00406-9"},{"key":"ref-29","unstructured":"Thumboo J, Tham SN, Tay YK, Chee T, Mow B, Chia HP, et al. Patterns of psoriatic arthritis in Orientals. J Rheumatol 1997;24:1949-53."},{"key":"ref-30","unstructured":"Jamshidi F, Bouzari N, Seirafi H, Farnaghi F, Firooz A. The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran. Arch Iran Med 2008;11:162-5."},{"key":"ref-31","doi-asserted-by":"crossref","unstructured":"Tam LS, Leung YY, Li EK. Psoriatic arthritis in Asia. Rheumatology (Oxford) 2009;48:1473-7. doi: 10.1093\/rheumatology\/kep230.","DOI":"10.1093\/rheumatology\/kep230"},{"key":"ref-32","doi-asserted-by":"crossref","unstructured":"Alenius GM, Jidell E, Nordmark L, Rantap\u00e4\u00e4 Dahlqvist S. Disease manifestations and HLA antigens in psoriatic arthritis in northern Sweden. Clin Rheumatol 2002;21:357-62. doi: 10.1007\/s100670200097.","DOI":"10.1007\/s100670200097"},{"key":"ref-33","unstructured":"Love TJ, Gudbjornsson B, Gudjonsson JE, Valdimarsson H. Psoriatic arthritis in Reykjavik, Iceland: Prevalence, demographics, and disease course. J Rheumatol 2007;34:2082-8."},{"key":"ref-34","doi-asserted-by":"crossref","unstructured":"Kerola AM, Sexton J, Wibetoe G, Rollefstad S, Crowson CS, Mars N, et al. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway. Semin Arthritis Rheum 2021;51:1081-8. doi: 10.1016\/j. semarthrit.2021.08.006.","DOI":"10.1016\/j.semarthrit.2021.08.006"},{"key":"ref-35","doi-asserted-by":"crossref","unstructured":"Tarannum S, Leung YY, Johnson SR, Widdifield J, Strand V, Rochon P, et al. Sex- and genderrelated differences in psoriatic arthritis. Nat Rev Rheumatol 2022;18:513-26. doi: 10.1038\/ s41584-022-00810-7.","DOI":"10.1038\/s41584-022-00810-7"},{"key":"ref-36","unstructured":"Roussou E. Spondyloarthritis in African populations compared to Europeans living in the United Kingdom. Mediterr J Rheumatol 2020;32:39-55. doi: 10.31138\/ mjr.32.1.39."}],"container-title":["Archives of Rheumatology"],"original-title":[],"link":[{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1423\/2538","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1423\/2539","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/download\/1423\/2538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:01:14Z","timestamp":1761210074000},"score":1,"resource":{"primary":{"URL":"https:\/\/archivesofrheumatology.org\/index.php\/pub\/article\/view\/1423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,30]]}},"URL":"https:\/\/doi.org\/10.46497\/archrheumatol.2024.10591","relation":{},"ISSN":["2618-6500"],"issn-type":[{"value":"2618-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}